Ixekizumab Halts Bone Damage in Axial Spondyloarthritis ...Middle East

Medscape - News
Ixekizumab Halts Bone Damage in Axial Spondyloarthritis
Ixekizumab reduces erosion and increases backfill in the sacroiliac joints of patients with radiographic axial spondyloarthritis by week 16, with continued improvement through week 52. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Ixekizumab Halts Bone Damage in Axial Spondyloarthritis )

Also on site :